Table 1 Cytotoxic activity of 1–7 against breast tumor and normal cell lines.
Compound | Cytotoxicity, IC50, μM | ||||||
---|---|---|---|---|---|---|---|
Breast cancer cell lines | Normal cell lines | ||||||
MCF-7 | 4T1 | H9C2 | 3T3 | HEKa | MDCK | A7r5 | |
Na2SeO3 | 17.1 ± 2.4 | 4.9 ± 0.6 | 1.5 ± 0.3 | 22.3 ± 3.6 | 13.3 ± 1.1 | 6.3 ± 0.4 | 39.4 ± 8.2 |
Doxorubicin | 1.0 ± 0.3 | 0.16 ± 0.06 | 11.0 ± 1.0 | 0.75 ± 0.09 | n.t | 57.0 ± 6.1 | 1.82 ± 0.35 |
1 | 3.10 ± 0.03 | 0.30 ± 0.03 | 1.8 ± 0.1 | 0.13 ± 0.02 | 2.31 ± 0.02 | 3.26 ± 0.40 | 2.89 ± 0.42 |
2 | 0.39 ± 0.03 | 1.1 ± 0.08 | 4.2 ± 0.3 | 1.6 ± 0.3 | 2.78 ± 0.08 | 6.27 ± 0.29 | 1.87 ± 0.26 |
3 | 0.50 ± 0.02 | 0.044 ± 0.005 | 2.2 ± 0.1 | 0.39 ± 0.05 | 2.21 ± 0.02 | 2.91 ± 0.13 | 1.85 ± 0.22 |
4 | 1.48 ± 0.04 | 0.45 ± 0.02 | 2.9 ± 0.1 | 0.79 ± 0.02 | 2.05 ± 0.05 | 2.54 ± 0.57 | 1.93 ± 0.16 |
5 | 0.29 ± 0.01 | 0.41 ± 0.05 | 9.3 ± 0.2 | 0.98 ± 0.03 | 2.01 ± 0.08 | 1.51 ± 0.37 | 1.92 ± 0.44 |
6 | 3.23 ± 0.03 | 1.7 ± 0.2 | 3.7 ± 0.2 | 7.4 ± 0.8 | 2.84 ± 0.08 | 6.58 ± 0.33 | 1.97 ± 0.27 |
7 | 1.48 ± 0.02 | 0.94 ± 0.06 | 0.67 ± 0.02 | 2.2 ± 0.3 | 2.19 ± 0.09 | 4.28 ± 0.34 | 1.66 ± 0.25 |